Powering Precision in Spatial Biology
Our Technology Partners
Biocare’s Technology Partners: Powering Precision in Spatial Biology
At Biocare, we are committed to providing the most advanced and reliable staining instrumentation for research and clinical labs worldwide. To complement our state-of-the-art equipment, we partner with industry-leading technology innovators to push the boundaries of spatial biology. Our partners’ cutting-edge capabilities align seamlessly with Biocare’s staining systems, enabling users to achieve high-precision, reproducible results in both research and translational applications. Together, we empower scientists and clinicians around the globe to unlock new insights in tissue biology, cancer research, and beyond.
By combining the power of these innovative technologies with Biocare’s staining platforms, researchers can unlock new possibilities in spatial biology, making groundbreaking discoveries in translational and clinical applications. Explore how these partnerships can enhance your lab’s capabilities and drive meaningful results.
Akoya Biosciences
Akoya specializes in multiplexed imaging solutions, enabling researchers to visualize over 100 biomarkers on a single tissue section. Their platforms, including the PhenoCycler®-Fusion and PhenoImager® HT, are widely recognized for enabling ultrahigh-plex, high-throughput, whole-slide, and high-resolution spatial biology at unprecedented speed. Akoya’s spatial toolbox is supported by two best-in-class chemistries. The first is PhenoCode™ chemistry, which leverages a barcoding approach to provide scalability and gentleness, allowing for a simple and efficient assay design while preserving tissue integrity. The second is the gold-standard Opal™-TSA chemistry, widely known in mIHC and mIF for its superior signal detection powered by amplification.Akoya’s technology when combined with Biocare’s automated staining instrumentation, provides researchers with a robust toolbox for deep spatial phenotyping in fields such as immuno-oncology, neuroscience, and more.
Ultivue
Ultivue offers proprietary InSituPlex® technology for fast, multiplexed biomarker detection in tissue samples. Their highly specific and sensitive assays enable simultaneous visualization of multiple proteins, making them an excellent match for Biocare’s staining instrumentation.
In addition, Ultivue’s VUE™ Biomarker Panels provide pre-validated panels of biomarkers tailored for specific research applications, including immuno-oncology and pathology. These panels accelerate the workflow, offering ready-to-use solutions that deliver reliable, spatially resolved data for translational research and clinical applications.
Molecular Instruments
Molecular Instruments® is at the forefront of RNA and protein imaging innovation with its proprietary HCR™ imaging platform, renowned for its class-leading versatility and performance. Their HCR™ Pro RNA-ISH assay enables researchers to detect RNA targets in tissue samples with unmatched precision, seamlessly integrating with existing IHC and IF workflows. Seamlessly compatible with Biocare’s staining platforms, HCR™ Pro products enable robust, automated, high-throughput workflows. This partnership leverages the strengths of both platforms to drive advancements in complex research areas, including cancer biology, neurobiology, and developmental biology, offering unprecedented efficiency and clarity in bioimaging.
Cell Signaling Technology
Cell Signaling Technology (CST) is renowned for its high-quality antibodies and cutting-edge solutions in signal detection. Their SignalStar™ Multiplex IHC technology allows for superior signal amplification and sensitivity in multiplexed assays, making it an ideal fit for Biocare’s staining platforms.
This technology ensures high specificity and reproducibility, allowing researchers to detect even low-abundance biomarkers with confidence. CST’s reagents, especially in combination with SignalStar, are widely used in cancer signaling pathway research, driving advancements in both R&D and clinical diagnostics.
